ArticleProstate international2026

A cfDNA-based DNA methylation classifier for distinguishing prostate cancer from benign prostatic hyperplasia.

Jong Hoo Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.